Product Program year 2020 Source: CMS Open Payments

Confirm RX

Device Cardiac Arrhythmias and Heart Failure

Open in the dashboard

General payments

$1,050,140

15,347 payments

Research payments

$225,324

171 payments

Through program year 2020, $1,050,140 in general payments and $225,324 in research payments were reported against Confirm RX (Cardiac Arrhythmias and Heart Failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 General $461,534 6,566
2020 Research $225,324 171
2019 General $588,606 8,781

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $1,050,140 15,347 payments
Top recipients General payments · program year 2020
  1. Childrens Hospital Medical Center Teaching hospital · OH $50,000 11% · 1 payment
  2. Robert Percell Cardiovascular Disease · Lincoln, NE $12,228 3% · 11 payments
  3. Harish Manyam Clinical Cardiac Electrophysiology · Chattanooga, TN $10,670 2% · 15 payments
  4. Andrew Rubin Clinical Cardiac Electrophysiology · Rancho Mirage, CA $8,271 2% · 9 payments
  5. Aysha Arshad Clinical Cardiac Electrophysiology · Manassas, VA $6,862 1% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Clinical Cardiac Electrophysiology Internal Medicine $176,559 46% · 606 practitioners
  2. Cardiovascular Disease Internal Medicine $123,833 32% · 1,064 practitioners
  3. Interventional Cardiology Internal Medicine $45,077 12% · 436 practitioners
  4. Internal Medicine $12,657 3% · 134 practitioners
  5. Family Medicine $7,186 2% · 60 practitioners

The top 5 of 56 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Texas $67,549 15% · 438 recipients
  2. California $65,837 14% · 336 recipients
  3. Ohio $55,386 12% · 23 recipients
  4. Florida $42,159 9% · 317 recipients
  5. New Jersey $23,448 5% · 148 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

15,347 general · 171 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record